Standard Biotools (LAB) Net Margin Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 399.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1,018.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Standard Biotools | 344.96 Mn | -110.22 Mn | 11.31 Mn | 73,727.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73,727.00 |
| Dec 31, 2025 | -187.00 |
| Sep 30, 2025 | -4,726.00 |
| Jun 30, 2025 | 25,725.00 |
| Mar 31, 2025 | 27,457.00 |
| Sep 30, 2024 | -5,068.00 |
| Jun 30, 2024 | -5,780.00 |
| Mar 31, 2024 | -1,331.00 |
| Dec 31, 2023 | 11,377.00 |
| Sep 30, 2023 | -6,792.00 |
| Jun 30, 2023 | -1,165.00 |
| Mar 31, 2023 | 44,828.00 |
| Dec 31, 2022 | 3,186.00 |
| Sep 30, 2022 | -6,615.00 |
| Jun 30, 2022 | -28,968.00 |
| Mar 31, 2022 | -20,317.00 |
| Sep 30, 2021 | 236.00 |
| Jun 30, 2021 | 613.00 |
| Mar 31, 2021 | -484.00 |
| Dec 31, 2020 | -288.00 |